Sumatriptan News
Migraine drugs to be fully funded
Rizatriptan Wafers, a medication that treats migraine headaches, will be fully funded from June 1, government drug-buying agency Pharmac said.
Aurobindo gets approval for Sumatriptan Succinate tabs
Aurobindo Pharma Limited is pleased to announce that the company has received tentative approval from the US Food & Drug Administration to manufacture and market Sumatriptan Succinate Tablets 25mg, 50mg and 100mg.
Spectrum Pharmaceuticals announces that sumatriptan injection litigation with GlaxoSmithKline® has been dismissed pursuant to the settlement agreement
Spectrum Pharmaceuticals, Inc. announced today that patent litigation relating to sumatriptan injection, the generic version of GlaxoSmithKline's Imitrex® Injection, has been dismissed by the United States District Court for the...
Pozen sinks on FDA request
Shares of Pozen Inc. tumbled Wednesday on news that regulators want additional data for its proposed migraine medication Trexima before they will consider approving the drug.
The Holidays Can Be A Headache for Millions of Americans But for Some, The Headache May Actually Be A Migraine
The hustle and bustle of the holidays can be exciting but can also be fraught with migraine triggers that can ruin everything for those that are at risk. More than 28 million Americans suffer from migraines, and exposure to...